๐—ฃ๐—น๐—ฎ๐˜€๐˜๐—ถ๐—ฐ p๐—ฎ๐—ฐ๐—ธ๐—ฎ๐—ด๐—ถ๐—ป๐—ด ๐—ถ๐—ป ๐˜๐—ต๐—ฒ p๐—ต๐—ฎ๐—ฟ๐—บ๐—ฎ๐—ฐ๐—ฒ๐˜‚๐˜๐—ถ๐—ฐ๐—ฎ๐—น ๐—ฆ๐—ฒ๐—ฐ๐˜๐—ผ๐—ฟ: c๐—ฎ๐—ป i๐˜ b๐—ฒ m๐—ผ๐—ฟ๐—ฒ s๐˜‚๐˜€๐˜๐—ฎ๐—ถ๐—ป๐—ฎ๐—ฏ๐—น๐—ฒ?

5 juni 2025

A consortium—established with TNO in collaboration with Janssen Biologics B.V., Bristol Myers Squibb, RENOLIT Healthcare Solutions, Avantor, Thermo Fisher Scientific, Wittenburg Group, HALIX and Polymer Science Park—believes it can.

Together, they are exploring how to make it easier to recycle plastics used in the production process into new packaging materials.

Plastics are often essential in pharmaceutical manufacturing to ensure hygiene and safety. However, they also contribute significantly to waste and COโ‚‚ emissions across the production and supply chain. That’s why the members of this consortium are working together to develop a better process for recycling these plastics into packaging.

To do so, first the high-performance materials used in current packaging need to be identified. Then

they first need to identify the high-performance materials used in current packaging and determine how they can best be reused. What makes this project unique is the ambition to reintroduce the recycled materials back into the pharmaceutical industry itself, closing the loop. Moreover, the entire value chain is involved from the start, which is key to creating real impact.

Together, we’re taking a circular step forward!

Altijd op de hoogte blijven?